Comparing Brief Behavioral Therapy (BBT-CI) and Healthy Eating Education Learning (HEAL) for Cancer-Related Sleep Problems While Receiving Chemotherapy
Purpose
This phase III trial compares BBT-CI to HEAL for the reduction of insomnia in patients with stage I-IV cancer who are receiving cancer treatment. Cancer treatment can cause side effects such as sleep problems. Sleep problems such as insomnia, are common for cancer patients. Insomnia can be described as difficulty falling asleep, waking up many times during the night or waking up earlier than patient would like. Insomnia can increase fatigue and worsen quality of life. This trial may help researchers determine which treatment works better in reducing insomnia, BBT-CI or HEAL.
Conditions
- Hematopoietic and Lymphoid Cell Neoplasm
- Malignant Solid Neoplasm
Eligibility
- Eligible Ages
- Over 18 Years
- Eligible Genders
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- Be at least 18 years of age - Be diagnosed with cancer (stage I, II, III, or IV) with a life expectancy of at least 12 months - Be currently receiving any cancer treatment (surgery alone is excluded) - Report sleep disturbance of 3 or greater on the sleep disturbance question: "Rate your sleep disturbance in the past 2 weeks on a scale from 0-10, 0 is no problems and 10 is having the most severe problems" - Have a score of 2, 1, or 0 on the Eastern Cooperative Oncology Group (ECOG) performance status scale - Be able to speak, understand and read English to participate in the study assessments and interventions
Exclusion Criteria
- Have a clinical diagnosis of obstructive sleep apnea or restless leg syndrome (even if controlled) - Be engaged in a formal Cognitive Behavioral Therapy for Insomnia program presently or in the past 30 days. Use of psychotropics and sleep medication are allowed
Study Design
- Phase
- Phase 3
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel Assignment
- Primary Purpose
- Supportive Care
- Masking
- Triple (Participant, Investigator, Outcomes Assessor)
Arm Groups
Arm | Description | Assigned Intervention |
---|---|---|
Experimental Group I (BBT-CI) |
Patients complete face to face/video sessions with a trained staff member. Patients also complete phone sessions. |
|
Active Comparator Group II (HEAL) |
Patients complete face to face/video sessions with a trained staff member. Patients also complete phone sessions. |
|
Recruiting Locations
Kingman, Arizona 86401
Fort Smith, Arkansas 72903
Oakland, California 94612
Denver, Colorado 80205
Lafayette, Colorado 80026
Lone Tree, Colorado 80124
Frankford, Delaware 19945
Newark, Delaware 19713
Newark, Delaware 19713
Rehoboth Beach, Delaware 19971
'Aiea, Hawaii 96701
'Aiea, Hawaii 96701
Honolulu, Hawaii 96813
Honolulu, Hawaii 96813
Honolulu, Hawaii 96813
Honolulu, Hawaii 96813
Honolulu, Hawaii 96813
Honolulu, Hawaii 96813
Honolulu, Hawaii 96817
Honolulu, Hawaii 96826
Bloomington, Illinois 61704
Canton, Illinois 61520
Carbondale, Illinois 62902
Carterville, Illinois 62918
Centralia, Illinois 62801
Danville, Illinois 61832
Decatur, Illinois 61526
Decatur, Illinois 62526
Decatur, Illinois 62526
Decatur, Illinois 62526
Effingham, Illinois 62401
Galesburg, Illinois 61401
O'Fallon, Illinois 62269
Pekin, Illinois 61554
Peoria, Illinois 61615
Urbana, Illinois 61801
Washington, Illinois 61571
Cedar Rapids, Iowa 52402
Des Moines, Iowa 50309
Des Moines, Iowa 50309
New Orleans, Louisiana 70112
New Orleans, Louisiana 70112
Elkton, Maryland 21921
Grand Rapids, Michigan 49503
Burnsville, Minnesota 55337
Coon Rapids, Minnesota 55433
Edina, Minnesota 55435
Maplewood, Minnesota 55109
Maplewood, Minnesota 55109
Minneapolis, Minnesota 55407
Minneapolis, Minnesota 55415
Minneapolis, Minnesota 55426
Monticello, Minnesota 55362
New Ulm, Minnesota 56073
Saint Louis Park, Minnesota 55416
Saint Paul, Minnesota 55101
Saint Paul, Minnesota 55101
Shakopee, Minnesota 55379
Willmar, Minnesota 56201
Woodbury, Minnesota 55125
Wyoming, Minnesota 55092
Ballwin, Missouri 63011
Joplin, Missouri 64804
Saint Louis, Missouri 63128
Saint Louis, Missouri 63141
Springfield, Missouri 65804
Springfield, Missouri 65804
Henderson, Nevada 89052
Henderson, Nevada 89052
Henderson, Nevada 89074
Henderson, Nevada 89074
Las Vegas, Nevada 89102
Las Vegas, Nevada 89106
Las Vegas, Nevada 89128
Las Vegas, Nevada 89128
Las Vegas, Nevada 89128
Las Vegas, Nevada 89128
Las Vegas, Nevada 89135
Las Vegas, Nevada 89144
Las Vegas, Nevada 89144
Las Vegas, Nevada 89144
Las Vegas, Nevada 89148
Las Vegas, Nevada 89148
Las Vegas, Nevada 89169
Marietta, Nevada 45750
Nags Head, North Carolina 27959
Winston-Salem, North Carolina 27104
Belpre, Ohio 45714
Columbus, Ohio 43213
Columbus, Ohio 43219
Dayton, Ohio 45459
Grove City, Ohio 43123
Mount Vernon, Ohio 43050
Newark, Ohio 43055
Westerville, Ohio 43081
Newberg, Oregon 97132
Oregon City, Oregon 997045
Portland, Oregon 97213
Portland, Oregon 97225
Chadds Ford, Pennsylvania 19317
Danville, Pennsylvania 17822
Dayton, Pennsylvania 17822
Hazleton, Pennsylvania 18201
Lewisburg, Pennsylvania 17837
Pottsville, Pennsylvania 17901
Scranton, Pennsylvania 18510
Wilkes-Barre, Pennsylvania 18711
Charleston, South Carolina 29401
Charleston, South Carolina 29403
Charleston, South Carolina 29406
Charleston, South Carolina 29414
Charleston, South Carolina 29414
Charleston, South Carolina 29414
Mount Pleasant, South Carolina 29464
Chesapeake, Virginia 23320
Fredericksburg, Virginia 22408
Lynchburg, Virginia 24501
Richmond, Virginia 23230
Richmond, Virginia 23235
Richmond, Virginia 23298
South Hill, Virginia 23970
Winchester, Virginia 22601
Bellingham, Washington 98225
Sedro-Woolley, Washington 98284
Appleton, Wisconsin 54911
Eau Claire, Wisconsin 54701
Green Bay, Wisconsin 54301
Green Bay, Wisconsin 54301
Green Bay, Wisconsin 54303
New Richmond, Wisconsin 54017
More Details
- NCT ID
- NCT04829539
- Status
- Recruiting
- Sponsor
- University of Rochester NCORP Research Base
Detailed Description
PRIMARY OBJECTIVE: I. Determine the efficacy of BBT-CI compared to HEAL for treating insomnia as measured by the Insomnia Severity Index (ISI) at post-intervention. SECONDARY OBJECTIVE: I. Determine the efficacy of BBT-CI compared to HEAL for improving sleep efficiency as measured via actigraphy at post-intervention. MECHANISTIC OBJECTIVES: I. Examine the efficacy of BBT-CI compared to HEAL for regulating circadian rhythms as measured via actigraphy (i.e., Mesor, Acrophase, Amplitude, I<O dichotomy index). EXPLORATORY OBJECTIVES: I. Examine potential moderators of BBT-CI effects on insomnia (ISI). II. Examine potential mediators of BBT-CI effects on insomnia (ISI). III. Determine the efficacy of BBT-CI compared to HEAL for treating insomnia as measured by the Insomnia Severity Index at the 6-month follow-up. IV. Determine the efficacy of BBT-CI compared to HEAL for improving sleep efficiency as measured via actigraphy at the 6-month follow-up. OUTLINE: Patients are randomized to 1 of 2 groups. GROUP I (BBT-CI): Patients complete face to face/video sessions with a trained staff member. Patients also complete phone sessions. GROUP II (HEAL): Patients complete face to face/video sessions with a trained staff member. Patients also complete phone sessions. After completion of study, patients are followed for up to 6 months.